Abstract
Background
Gallbladder carcinoma is a highly lethal but relatively rare neoplasm of the digestive tract. p53 mutations are one of the most frequent genetic alterations in human cancers and are thought to play a role in pathogenesis of several malignancies. Kras oncogene is responsible for high frequency recognized as an early event in pancreatic and colonic carcinogenesis.
Objectives
We investigated the genetic change of p53, Kras and histopathological changes in gallbladder cancer tissue samples.
Methods
P53 mutation was seen in the axons 5, 6, 7 and 8 of p53 gene and Kras codon 12 mutations in 25 operative specimens of gallbladder carcinoma. The hispathology observations and polymerase chain reaction-based techniques of these patients were used for point mutations study in p53 and in codon 12 of Kras gene.
Results
Mutations of p53 analyzed from exons 5 to 8 using the method of PCR-SSCP were 44%, PCR-RFLP was carried out, and incidence of mutation in codon 12 of Kras was 48% in the adenocarcinoma patients. There was a significant correlation between presence of gall stone, histopathological type, cellular differentiation, grade, lymphovascular invasion, perineural invasion, lymph node invasion, involvement of cystic duct end margin, liver invasion, omental tissue invasion, and T.N.M. staging.
Conclusions
Curative surgical resection remains the only effective approach for treatment of GBC. Studies with large number of cases with latest application, next-generation sequencing, DNA microarray, transcriptome analysis, and real-time PCR would help in exploring more targets and better classification of these cancers at genetic level.
Similar content being viewed by others
References
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. J Clin Epidemiol. 2014;6:99–109.
Misra S, Chaturvedi A, Goel MM, Mehrotra R, Sharma ID, Srivastava AN, et al. Overexpression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol. 2000;26:164–7.
Chantarojanasiri T, Hirooka Y, Kawashima H, Ohno E, Kongkam P, Goto H. The role of endoscopic ultrasound in the diagnosis of gallbladder diseases. J Med Ultrasound. 2017;44(1):63–70.
Murthy NS, Rajaram D, Gautham MS, Shivraj NS, Sreekantaiah P, Preethi SG, et al. Trends in incidence of gallbladder cancer-Indian scenario. Gastrointestinal Cancer. Target Ther. 2011;1:1–9.
Sicklick JK, Fanta PT, Shimabukuro K, Kurzrock R. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design. Cancer Metastasis Rev. 2016;35(2):263–75.
Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM. Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005;116:740–54.
Kumari S, Tewari S, Husain N, Agarwal A, Pandey A, Singhal A, et al. Quantification of circulating free DNA as a diagnostic marker in gallbladder cancer. Pathol Oncol Res. 2017;23(1):91–7.
Shukla SK, Singh G, Shahi KS, Bhuvan PP. Staging, treatment and future approaches of gallbladder carcinoma. J Gastrointest Cancer. 2018;49(1):9–15.
Li M, Chen L, Qu Y, Sui F, Yang Q, Ji M, et al. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. Oncotarget. 2017;8(22):36319–30.
Bodzioch S, Ogiela MR. New approach to gallbladder ultrasonic images analysis and lesions recognition. Comput Med Imaging Graph. 2009;33:154–70.
Kumari S, Husain N, Agarwal A, Neyaz A, Gupta S, Chaturvedi A, et al. Diagnostic value of circulating free DNA integrity and global methylation status in gallbladder carcinoma. Pathol Oncol Res. 2018;1:12.
Sharma M, Somani P, Sunkara T. Imaging of gall bladder by endoscopic ultrasound. World J Gastrointest Endosc. 2018;10(1):10–5.
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.
Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of the biliary tract. 4th ed. Tokyo: Kanehara; 1997.
Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system (WHO classification of tumours volume 3), vol. 417. 4th ed. Lyon: IARC Press; 2010.
Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of the biliary tract. 5th ed. Tokyo: Kanehara; 2013.
Wang N, Xiang X, Chen K, Liu P, Zhu A. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma. Biochimie. 2018;146:56–67.
Zulpo M, Balbus J, Kuropka P, Kubica K. A model of gallbladder motility. Comput Biol Med. 2018;93:139–48.
Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, et al. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. 2014;45(4):701–8.
Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–64.
Rashid A, Ueki T, Gao YT, Houlihan PS, Wallace C, Wang BS, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res. 2002;8:3156–63.
Vousden KH, Lu X. Live or let die: the cell’s response to p53. Nat Rev Cancer. 2002;2:594–604.
Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroentero. 1994;107(4):1147–53.
Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995;55(12):2511–5.
Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut. 1996;38:426–9.
Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Iwao T, et al. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur J Cancer. 1997;33(7):1136–40.
Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 1998;83:267–75.
Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Sci. 2000;7:426–31.
Singh MK, Chetri K, Pandey UB, Kapoor VK, Mittal B, Choudhuri G. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol. 2004;19:916–21.
Cho NY, Choi M, Kim BH, Cho YM, Moon KC, Kang GH. BRAF and KRAS mutations in prostatic adenocarcinoma. Int J Cancer. 2006;119:1858–62.
Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, et al. Genetic changes of p53, K-ras and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. W J Gastroenterol. 2008;14:70–5.
Kazmi HR, Chandra A, Nigam J, Noushif M, Parmar D, Gupta V. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer. Dig Surg. 2013;30(3):233–9.
Takagi S, Naito E, Yamanouchi H, Ohtsuka H, Kominami R, Yamamoto M. Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med. 1994;172:283–9.
Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pat. 1995;144(3):511–7.
Puhalla H, Kandioler D, Ludwig C, Filipits M, Wrba F, Laengle F, et al. p53 analysis in gallbladder cancer: comparison of gene analysis versus immunohistochemistry. Anticancer Res. 2004;24:1201–6.
Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T. Correlation of p53 protein expression with gene mutation in gallbladder carcinomas. Pathol Int. 1997;47:525–30.
Yokoyama N, Hitomi J, Watanabe H, Ajioka Y, Pruyas M, Serra I, et al. Mutations of p53 in gallbladder carcinomas in high incidence areas of Japan and Chile. Cancer Epidemiol Biomark. 1998;7:297–301.
Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer. 1996;77:452–8.
Chaube A, Tewari M, Garbyal RS, Singh U, Shukla HS. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients. BMC Cancer. 2006;10(6):126.
Nigam P, Misra U, Negi TS, Mittal B, Choudhuri G. Alterations of p53 gene in gallbladder cancer patients of North India tropical. Gastroenterol. 2010;31(2):96–100.
Acknowledgments
I appreciate the supporting staff of Multidisciplinary Research Unit who contributed to this research work. I am thankful to the surgery department faculty and supporting staff for giving patient’s information and gallbladder sample and processing for study. I acknowledge to pathology department for histopathological finding and data collection of gallbladder carcinoma samples and also to Principal, Government Medical College, Haldwani, Nainital, Uttarakhand for the research place for this work in Multidisciplinary Research Unit laboratory.
Funding
The Department of Health and Research, Ministry of Health & Family Welfare, New Delhi, India provided supporting fund.
Author information
Authors and Affiliations
Contributions
Sanjeev Kumar Shukla helped to draft the manuscript and in the collection and preparation of data, figure, and table. Govind Singh carried out the design of the study, performed the acquisition of data, and approved the final version of the manuscript. Bhuvan and K.S. Shahi provided the positive samples of the gallbladder carcinoma. Prabhat Pant conceived the study and pathological analysis, participated in its design, and helped in sample screening. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shukla, S.K., Singh, G., Shahi, K.S. et al. Genetic Changes of P53 and Kras in Gallbladder Carcinoma in Kumaon Region of Uttarakhand. J Gastrointest Canc 51, 552–559 (2020). https://doi.org/10.1007/s12029-019-00283-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-019-00283-0